SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 201–300 of 1,001
The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB
Liu, Z., Pan, Q., Liang, Z., Qiao, W., Cen, S., & Liang, C. (2015) · Retrovirology · doi:10.1186/s12977-014-0129-1 · Cited by 93
“Examples of these restriction factors include APOBEC3G [1], Trim5α [2], tetherin [3,4], and SAMHD1 [5,6] (reviewed in [7]).”
SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cells
Bonifati, S., Daly, M. B., Gelais, C. S., Kim, S., Hollenbaugh, J. A., Shepard, C., Kennedy, E. M., Kim, D.-H., Schinazi, R. F., Kim, B., et al. (2016) · Virology · doi:10.1016/j.virol.2016.05.002 · Cited by 105
“In 2011, two laboratories independently identified SAMHD1 as a host restriction factor inhibiting human immunodeficiency virus type 1 (HIV-1) infection in non-dividing myeloid cells (Hrecka et al., 2011; Laguette et al., 2011).”
InfluentialSAMHD1 specifically restricts retroviruses through its RNase activity
Choi, J., Ryoo, J., Oh, C., Hwang, S.-Y., & Ahn, K. (2015) · Retrovirology · doi:10.1186/s12977-015-0174-4 · Cited by 94
“and quiescent CD4+ T cells [14–17].”
Innate Immune Recognition of HIV-1
Iwasaki, A. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.011 · Cited by 101
Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread
Cenker, J. J., Stultz, R. D., & McDonald, D. J. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0004 · Cited by 90
CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases
Sharma, P., & Nag, A. (2014) · Open Biology · doi:10.1098/rsob.130217 · Cited by 99
Emerging Role of the Host Restriction Factor Tetherin in Viral Immune Sensing
Hotter, D., Sauter, D., & Kirchhoff, F. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.09.029 · Cited by 95
Martín‐Gayo, E., Buzón, M. J., Ouyang, Z., Hickman, T. L., Cronin, J., Pimenova, D., Walker, B. D., Lichterfeld, M. D., & Yu, X. G. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004930 · Cited by 97
SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity
Antonucci, J. M., Gelais, C. S., de Silva, S., Yount, J. S., Tang, C., Ji, X., Shepard, C., Xiong, Y., Kim, B., & Wu, L. J. (2016) · Nature Medicine · doi:10.1038/nm.4163 · Cited by 86
SAMHD1 protects cancer cells from various nucleoside-based antimetabolites
Herold, N., Rudd, S. G., Sanjiv, K., Kutzner, J., Bladh, J., Paulin, C. B. J., Helleday, T., Henter, J., & Schaller, T. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1314407 · Cited by 94
“Sterile a motif and histidine/aspartic acid domain containing protein 1 (SAMHD1) was identified in 2011 to restrict human immunodeficiency virus type 1 (HIV-1) in myeloid cells, a breakthrough in unravelling the, up to then, enigmatic reasons underlying the low permissivity of macrophages or dendritic cells to HIV-1 i…”
BackgroundPlasmacytoid Dendritic Cells in HIV Infection
O’Brien, M. P., Manches, O., & Bhardwaj, N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_3 · Cited by 96
“[PubMed: 21693759] Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature.”
BackgroundInfluentialInhibition of Hepatitis B virus replication by SAMHD1
Chen, Z., Zhu, M., Pan, X., Zhu, Y., Yan, H., Jiang, T., Shen, Y., Dong, X., Zheng, N., Lu, J., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.023 · Cited by 87
Hiding in Plain Sight: How HIV Evades Innate Immune Responses
Manel, N., & Littman, D. R. (2011) · Cell · doi:10.1016/j.cell.2011.09.010 · Cited by 76
GTP Is the Primary Activator of the Anti-HIV Restriction Factor SAMHD1
Amie, S. M., Bambara, R. A., & Kim, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.493619 · Cited by 85
“To overcome this restriction, some lentiviruses such as HIV-2 and several simian immunodeficiency viruses express the accessory protein Vpx to target SAMHD1 for proteasomal degradation (6, 7).”
BackgroundReverse Transcription of Retroviruses and LTR Retrotransposons
Hughes, S. H. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0027-2014 · Cited by 72
“SAMHD1, which is found, in an active form, in some non-dividing cells, catalyzes the conversion of dNTPs to their corresponding nucleosides and free triphosphate, and it can reduce the levels of dNTPs to a point where the reverse transcription of retroviruses is blocked (157, 158, 159, 160, 161, 162).”
BackgroundHijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins
Seissler, T., Marquet, R., & Paillart, J. (2017) · Viruses · doi:10.3390/v9110322 · Cited by 91
“SAMHD1 (Sterile Alpha Motif and Histidine Aspartate domain-containing protein 1) also targets the early phase of viral infection: this deoxynucleotide-triphosphohydrolase inhibits reverse transcription by depleting the pool of cellular dNTPs (deoxy Nucleotide TriPhosphates) [67,68].”
BackgroundInfluentialCellular regulation of ribonucleotide reductase in eukaryotes
Guarino, E., Salguero, I., & Kearsey, S. E. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.03.030 · Cited by 78
“The ability of SAMHD1 to lower dNTP levels blocks IV-1 replication, and inactivation of SAMHD1 alleviates restricion of viral replication [95–97].”
BackgroundThe Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis
Wacleche, V. S., Tremblay, C. L., Routy, J., & Ancuța, P. (2018) · Viruses · doi:10.3390/v10020065 · Cited by 96
“The function of SAMHD1 in cleaving dNTPs may explain the resistance of monocytes toward HIV infection [148,149].”
BackgroundInfluentialHow Samhd1 changes our view of viral restriction
Laguette, N., & Benkirane, M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.11.002 · Cited by 96
“In support of this hypothesis, SAMHD1 is active in differentiated noncycling cells, such as DCs and macrophages [6] that have low intracellular dNTP concentrations compared to proliferating cells [52] in which SAMHD1 is inefficient [7].”
BackgroundSelf-citationPromoter Methylation Regulates SAMHD1 Gene Expression in Human CD4+ T Cells
de Silva, S., Hoy, H., Hake, T. S., Wong, H. K., Porcu, P., & Wu, L. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447201 · Cited by 91
“Lower Levels of SAMHD1 Protein and mRNA Expression in CD4 T Cell Lines Compared with the THP-1 Monocytic Cell Line—A previous study indicated that THP-1 monocytic cells express high levels of SAMHD1, whereas the CD4 T cell lines Jurkat and Sup-T1 do not express detectable SAMHD1 protein (7).”
BackgroundResultFan, W., Mar, K. B., Sari, L., Gaszek, I. K., Cheng, Q., Evers, B. M., Shelton, J. M., Wight‐Carter, M., Siegwart, D. J., Lin, M. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.047 · Cited by 84
Dai, L., Lidie, K. B., Chen, Q., Adelsberger, J. W., Zheng, X. M., Huang, D.-W., Yang, J., Lempicki, R. A., Rehman, T. U., Dewar, R. L., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20120572 · Cited by 85
“More recently, SAMHD1, a restriction factor of myeloid cells, was found to limit HIV replication by depleting intracellular dNTPs, and it is largely opposed by Vpx (Hrecka et al., 2011; Laguette et al., 2011; Lahouassa et al., 2012).”
BackgroundMyeloid Cell Interaction with HIV: A Complex Relationship
Rodrigues, V., Ruffin, N., Jouve, M. J., & Benaroch, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01698 · Cited by 89
“This sensing step is macrophage specific as it does not occur in monocyte-derived dendritic cells (MDDCs) exposed to HIV-1 (Decalf et al., unpublished results).”
BackgroundInfluentialHIV-1 replicates and persists in vaginal epithelial dendritic cells
Peña‐Cruz, V., Agosto, L. M., Akiyama, H., Olson, A., Moreau, Y., Larrieux, J.-R., Henderson, A. J., Gummuluru, S., & Sagar, M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98943 · Cited by 81
“Host restriction factor SAMHD1 inhibits HIV-1 reverse transcription and subsequent integration in myeloid cells (19, 20).”
HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins
Hrecka, K., Hao, C., Shun, M.-C., Kaur, S., Swanson, S. K., Florens, L., Washburn, M. P., & Skowronski, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605023113 · Cited by 80
“Significantly, HIV-2/HIVsm viruses antagonize SAMHD1 dNTPase via their Vpx proteins (6, 7) whereas HIV-1/SIVcpz do not possess this ability.”
BackgroundImpaired dNTPase Activity of SAMHD1 by Phosphomimetic Mutation of Thr-592
Tang, C., Ji, X., Wu, L. J., & Xiong, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677435 · Cited by 81
LINE‐1 retrotransposons in healthy and diseased human brain
Suarez, N. A., Macia, Á., & Muotri, A. R. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22567 · Cited by 87
“SAMHD1 is a known inhibitor against certain retroviruses, including HIV and simian immunodeficiency virus (SIV) (Hrecka et al. 2011; Laguette et al. 2011).”
IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle
Coiras, M., Bermejo, M., Descours, B., Mateos, E., García‐Pérez, J., López‐Huertas, M. R., Lederman, M. M., Benkirane, M., & Alcamí, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.022 · Cited by 85
“The accessory protein Vpx of HIV-2 and the simian immunodeficiency virus (SIV) target SAMHD1 for ubiquitination and proteasomal degradation (Laguette et al., 2011).”
BackgroundSelf-citationInnate Immune Sensing of HIV-1 by Dendritic Cells
Luban, J. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.002 · Cited by 90
“SAMHD1 knockdown permitted HIV-1 reverse transcription to proceed in myeloid cells in the absence of Vpx (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundSingle-stranded nucleic acids promote SAMHD1 complex formation
Tüngler, V., Staroske, W., Kind, B., Dobrick, M., Kretschmer, S., Schmidt, F., Krug, C., Lorenz, M., Chara, O., Schwille, P., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-0995-3 · Cited by 85
Viral Determinants of HIV-1 Macrophage Tropism
Duncan, C. J. A., & Sattentau, Q. J. (2011) · Viruses · doi:10.3390/v3112255 · Cited by 86
“studies have identified a host SAM-domain HD-domain containing protein 1 (SAMHD1) as a target for Vpx-mediated proteosomal degradation, which overcomes a post-entry block to reverse transcription in myeloid cells [158,159].”
BackgroundCD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir
Badía, R., Ballana, E., Castellví, M., García-Vidal, E., Pujantell, M., Clotet, B., Prado, J. G., Puig, J., Martínez, M. Á., Riveira‐Muñoz, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05157-w · Cited by 84
N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation
Yamasoba, D., Sato, K., Ichinose, T., Imamura, T., Koepke, L., Joas, S., Reith, E., Hotter, D., Misawa, N., Akaki, K., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0460-3 · Cited by 82
An evolutionarily conserved transcriptional response to viral infection in Caenorhabditis nematodes
Chen, K., Franz, C., Jiang, H., Jiang, Y., & Wang, D. (2017) · BMC Genomics · doi:10.1186/s12864-017-3689-3 · Cited by 85
“8, the human ortholog of which is SAMHD1, an antiviral gene against human immunodeficiency virus 1 [35].”
BackgroundRegulation of cGAS and STING signaling during inflammation and infection
Chauvin, S. D., Stinson, W. A., Platt, D. J., Poddar, S., & Miner, J. J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104866 · Cited by 81
Aicardi–Goutières syndrome: a model disease for systemic autoimmunity
Lee‐Kirsch, M. A., Wolf, C., & Günther, C. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12160 · Cited by 84
MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells
Liu, S., Qiu, C., Miao, R., Zhou, J., Lee, A., Liu, B., Lester, S. N., Fu, W., Zhu, L., Zhang, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316208110 · Cited by 80
HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137
Zhang, F., & Bieniasz, P. D. (2020) · eLife · doi:10.7554/elife.55806 · Cited by 75
“Recruitment of CRL4 by virion-associated Vpx and some SIV Vpr proteins can induce the degradation of the antiviral protein SAMHD1 shortly following viral entry (Hrecka et al., 2011; Laguette et al., 2011; Spragg and Emerman, 2013).”
BackgroundPertel, T., Reinhard, C., & Luban, J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-49 · Cited by 74
The fate of influenza A virus after infection of human macrophages and dendritic cells
Short, K. R., Brööks, A. G., Reading, P. C., & Londrigan, S. L. (2012) · Journal of General Virology · doi:10.1099/vir.0.045021-0 · Cited by 82
“, 2010) and recently SAM domain and HD domain-containing protein 1 was identified as a dendritic and myeloid cell-specific restriction factor for HIV-1 (Laguette et al., 2011).”
BackgroundInfluentialMechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.
Gonzalo-Gil, E., Ikediobi, U., & Sutton, R. E. (2017) · PubMed Central · Cited by 107
Interferons: Reprogramming the Metabolic Network against Viral Infection
Raniga, K., & Liang, C. (2018) · Viruses · doi:10.3390/v10010036 · Cited by 82
Restricting HIV the SAMHD1 way: through nucleotide starvation
Ayinde, D., Casartelli, N., & Schwartz, O. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2862 · Cited by 86
Self-citationPontillo, A., da Silva, L. T., Oshiro, T. M., Finazzo, C., Crovella, S., & Duarte, A. J. S. (2011) · AIDS · doi:10.1097/qad.0b013e32834d697f · Cited by 80
“(Tripartite motif-containing protein 5 alpha/TRIM5a, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like/APOBEC-3G, tetherin) [2] and specifically in monocytes and dendritic cells (cyclophilin A, SAM domain and HD domain-containing protein 1/SAMHD1) [12,13] playing a key role in controlling viral replicat…”
BackgroundKoharudin, L. M. I., Wu, Y. G., DeLucia, M., Mehrens, J., Gronenborn, A. M., & Ahn, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591958 · Cited by 72
Wang, J., Teng, J. L. L., Zhao, D., Ge, P., Li, B., Woo, P. C. Y., & Liu, C. H. (2016) · Scientific Reports · doi:10.1038/srep34827 · Cited by 78
Vpr Overcomes Macrophage-Specific Restriction of HIV-1 Env Expression and Virion Production
Mashiba, M., Collins, D. R., Terry, V. H., & Collins, K. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.014 · Cited by 71
“Briefly, we spinoculated primary monocytes with VSV-G-pseudotyped SIV3+ for 2 hr with 10 mg/ml polybrene to allow Vpx-dependent downmodulation of SAMHD1.”
InfluentialPuigdomènech, I., Casartelli, N., Porrot, F., & Schwartz, O. (2012) · Journal of Virology · doi:10.1128/jvi.02514-12 · Cited by 76
“of SAMHD1 and -actin as described previously (7).”
BackgroundSelf-citationTartour, K., Nguyen, X.-N., Appourchaux, R., Assil, S., Barateau, V., Bloyet, L.-M., Burlaud Gaillard, J., Confort, M.-P., Escudero-Perez, B., Gruffat, H., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006610 · Cited by 69
“This trick allows a very efficient transduction of myeloid cells by HIV-1 [88] [89] [90] thanks to the reported ability of Vpx to remove the restriction factor SAMHD1 [91, 92] .”
BackgroundHIV-1 cell-to-cell transmission and broadly neutralizing antibodies
Dufloo, J., Bruel, T., & Schwartz, O. (2018) · Retrovirology · doi:10.1186/s12977-018-0434-1 · Cited by 69
Self-citationSARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells
Perez‐Zsolt, D., Muñoz‐Basagoiti, J., Rodon, J., Elosua-Bayés, M., Regué, D. R., Risco, C., Sachse, M., Pino, M., Gumber, S., Paiardini, M., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00794-6 · Cited by 78
Wei, W., Guo, H., Han, X., Liu, X., Zhou, X., Zhang, W., & Yu, X.-F. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01835.x · Cited by 73
“SIVmac Vpx targets SAMHD1 to DCAF1–DDB1–Cul4 E3 ubiquitin ligase complexes for polyubiquitination and proteasome-mediated degradation (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundInfluentialRestrictive influence of SAMHD1 on Hepatitis B Virus life cycle
Sommer, A. F. R., Rivière, L., Qu, B., Schott, K., Rieß, M., Ni, Y., Shepard, C., Schnellbächer, E., Finkernagel, M., Himmelsbach, K., et al. (2016) · Scientific Reports · doi:10.1038/srep26616 · Cited by 75
Conserved Herpesvirus Protein Kinases Target SAMHD1 to Facilitate Virus Replication
Zhang, K., Lv, D., & Li, R. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.020 · Cited by 69
“SAMHD1 is a newly defined anti-viral host restriction factor that limits the infection of human immunodeficiency virus-1 (HIV-1) (Laguette et al., 2011), HSV-1 (Hollenbaugh et al., 2013; Kim et al., 2013), vaccinia virus (Hollenbaugh et al., 2013), human T cell leukemia virus type 1 (Sze et al., 2013) and hepatitis B…”
BackgroundInfluentialDendritic Cells, the Double Agent in the War Against HIV-1
Martín-Moreno, A., & Muñoz‐Fernández, M. Á. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02485 · Cited by 75
“and HD-domain containing protein 1 (SAMHD1) was first described in 2011 as the restriction factor that gives non-dividing myeloid cells certain resistance against HIV-1 infection (110, 111).”
BackgroundHIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread
Kalinichenko, S., Komkov, D., & Mazurov, D. (2022) · Viruses · doi:10.3390/v14010152 · Cited by 68
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64], and the cytidine deaminase, APOBEC3G, induces hypermutation of the viral genome [65].”
BackgroundThe Role of Human Dendritic Cells in HIV-1 Infection
Ahmed, Z., Kawamura, T., Shimada, S., & Piguet, V. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.490 · Cited by 79
“However, the most likely potent restriction in DCs and myeloid cells is the recently identified SAMHD1, blocking at the post-entry step (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundTRIM21‐mediated proteasomal degradation of SAMHD1 regulates its antiviral activity
Li, Z., Huan, C., Wang, H., Liu, Y., Liu, X., Su, X., Yu, J., Zhao, Z., Yu, X., Zheng, B., et al. (2019) · EMBO Reports · doi:10.15252/embr.201847528 · Cited by 71
Romani, B., Shaykh Baygloo, N., Aghasadeghi, M. R., & Allahbakhshi, E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641522 · Cited by 63
HIV-1 Accessory Proteins Adapt Cellular Adaptors to Facilitate Immune Evasion
Collins, D. R., & Collins, K. L. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003851 · Cited by 61
“Vpx-mediated polyubiquitination of SAMHD1 induces its proteasomal degradation and allows viral replication in myeloid cells [27].”
BackgroundSubstrates and Inhibitors of SAMHD1
Hollenbaugh, J. A., Shelton, J. R., Tao, S., Amiralaei, S., Liu, P., Lu, X., Goetze, R. W., Zhou, L., Nettles, J. H., Schinazi, R. F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169052 · Cited by 69
Klockow, L. C., Sharifi, H. J., Wen, X., Flagg, M., Furuya, A. K. M., Nekorchuk, M. D., & de Noronha, C. M. C. (2013) · Virology · doi:10.1016/j.virol.2013.06.010 · Cited by 71
“SAMHD1 (Hrecka et al., 2011) also acts as a restriction that can be overcome by Vpx in monocyte-derived dendritic cells (Laguette et al., 2011).”
Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein
Lee, S. H., Albright, E. R., Lee, J.-H., Jacobs, D., & Kalejta, R. F. (2015) · Science Advances · doi:10.1126/sciadv.1501164 · Cited by 68
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
Johansson, P., Klein-Hitpass, L., Choidas, A., Habenberger, P., Mahboubi, B., Kim, B., Bergmann, A., Scholtysik, R., Brauser, M., Lollies, A., et al. (2018) · Blood Cancer Journal · doi:10.1038/s41408-017-0036-5 · Cited by 66
HIV-1 eradication strategies: design and assessment
Siliciano, J. D., & Siliciano, R. F. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328361eaca · Cited by 69
Ogawa, Y., Kawamura, T., Matsuzawa, T., Aoki, R., Gee, P., Yamashita, A., Moriishi, K., Yamasaki, K., Koyanagi, Y., Blauvelt, A., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2012.12.002 · Cited by 66
“In addition, APOBEC3G (A3G) and SAM domain and HD domain 1 (SAMHD1) has been recently shown to function as a potent postentry cellular restriction factor for HIV in DCs or LCs (Hrecka et al., 2011; Laguette et al., 2011; Ogawa et al., 2009; Pion et al., 2006).”
BackgroundEfferocytosis of Pathogen-Infected Cells
Karaji, N., & Sattentau, Q. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01863 · Cited by 70
“The restriction factor SAMHD1 renders DC relatively resistant to HIV-1 infection and limits DC activation and antigen presentation (135).”
BackgroundLiu, Y., Fu, Y., Wang, Q., Li, M., Zhou, Z., Dabbagh, D., Fu, C., Zhang, H., Li, S., Zhang, T., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0372-2 · Cited by 67
Lentivirus Vpr and Vpx accessory proteins usurp the cullin4–DDB1 (DCAF1) E3 ubiquitin ligase
Romani, B., & Cohen, É. A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.09.010 · Cited by 63
“Importantly, site-specific mutation of the crucial catalytic amino-acids of the HD domain responsible for the triphosphohydrolase activity of SAMHD1 was found to alleviate the restriction of HIV-1 infection in non-permissive cells [46 ], indicating that the antiviral activity of SAMHD1 would be mediated by an effect o…”
BackgroundInnate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease
Zaunders, J., & van Bockel, D. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00095 · Cited by 69
“Identified using mass-spectrometry as a counteracted target for the HIV-2/SIV protein Vpx (Laguette et al., 2011), SAMHD1 highlights the role of intrinsic host factors in limiting reservoir generation particularly in resting CD4 T cells.”
BackgroundImpact of cellular autophagy on viruses: Insights from hepatitis B virus and human retroviruses
Tang, S.-W., Ducroux, A., Jeang, K., & Neuveut, C. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-92 · Cited by 65
Pauls, E., Jiménez, E., Ruiz, A., Permanyer, M., Ballana, E., Costa, H., Nascimiento, R., Parkhouse, R. M. E., Peña, R., Riveira‐Muñoz, E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203226 · Cited by 63
SAMHD1’s protein expression profile in humans
Schmidt, S., Schenková, K., Adam, T., Erikson, E., Lehmann‐Koch, J., Sertel, S., Verhasselt, B., Fackler, O., Lasitschka, F., & Keppler, O. T. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4hi0714-338rr · Cited by 71
“Besides the major protein band at 72 kDa, seen in all tissues and reported previously in cell lines [11, 12], additional, prominent, lower molecular weight bands were noted, particularly in a spleen lysate (Fig.”
BackgroundDutartre, H., Clavière, M., Journo, C., & Mahieux, R. (2016) · Journal of Virology · doi:10.1128/jvi.00407-16 · Cited by 55
“Thus, DC-SIGN signaling may induce SAMHD-1 phosphorylation, that would then relieve restriction.”
InfluentialBaldauf, H., Stegmann, L., Schwarz, S.-M., Ambiel, I., Trotard, M., Martin, M., Burggraf, M., Lenzi, G. M., Lejk, H., Pan, X., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613635114 · Cited by 72
Structure-Guided Analysis of the Human APOBEC3-HIV Restrictome
Aydin, H., Taylor, M. W., & Lee, J. E. (2014) · Structure · doi:10.1016/j.str.2014.02.011 · Cited by 67
Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches
Santa‐Marta, M., de Brito, P. M., Godinho‐Santos, A., & Gonçalves, J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00343 · Cited by 72
“In cellular models using primary SIV, SAMHD1 restriction can also be overcome by transduction of cells with the Viral Protein R (Vpr) (289, 290).”
BackgroundLow dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1
Welbourn, S., & Strebel, K. (2015) · Virology · doi:10.1016/j.virol.2015.11.022 · Cited by 62
“…SAMHD1 is present in many actively dividing cell types, the restrictive effect has generally only been observed in differentiated/non-dividing cells (Baldauf et al., 2012; Berger et al., 2011; Descours et al., 2012; Hrecka et al., 2011; Laguette et al., 2011; St Gelais et al., 2012).”
InfluentialCoulon, P.-G. A., Richetta, C., Rouers, A., Blanchet, F. P., Urrutia, A., Guerbois, M., Piguet, V., Theodorou, I. D., Bet, A., Schwartz, O., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600286 · Cited by 67
“In particular in DC, SAMHD1, a cellular enzyme that depletes intracellular 29- deoxynucleoside 59-triphosphates and degrades viral RNA, interferes with reverse transcription, limiting viral replication (49, 50).”
BackgroundMethodInfluentialSelf-citationBhattacharya, A., Wang, Z., White, T. E., Buffone, C., Nguyen, L. A., Shepard, C., Kim, B., Demeler, B., Diaz‐Griffero, F., & Ivanov, D. N. (2016) · Scientific Reports · doi:10.1038/srep31353 · Cited by 62
“Early studies suggested that the dNTPase activity of the enzyme depletes cellular dNTP concentrations and thus inhibits reverse transcription of the viral genome 5,6,12,14 .”
Schott, K., Fuchs, N. V., Derua, R., Mahboubi, B., Schnellbächer, E., Seifried, J., Tondera, C., Schmitz, H., Shepard, C., Brandariz-Núñez, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04671-1 · Cited by 67
Su, J., Rui, Y., Lou, M., Yin, L., Xiong, H., Zhou, Z., Shen, S., Chen, T., Zhang, Z., Zhao, N., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0585-4 · Cited by 65
Nonhuman Primate Models for HIV/AIDS Vaccine Development
Sui, Y., Gordon, S. N., Franchini, G., & Berzofsky, J. A. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1214s102 · Cited by 67
“Another recently identified host factor is SAMHD, whose activity was confined to differentiated uncycling cells like macrophages and mDC (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundPeriodontal and other oral manifestations of immunodeficiency diseases
Peacock, M., Arce, R. M., & Cutler, C. W. (2016) · Oral Diseases · doi:10.1111/odi.12584 · Cited by 68
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript by inhibiting an early essential viral life cycle step (Laguette et al., 2011).”
BackgroundSAMHD1 and the innate immune response to cytosolic DNA during DNA replication
Coquel, F., Neumayer, C., Lin, Y., & Pasero, P. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.017 · Cited by 67
Mock, D. J., Hollenbaugh, J. A., Daddacha, W. B., Overstreet, M. G., Lazarski, C. A., Fowell, D. J., & Kim, B. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002635 · Cited by 69
“Several recent studies have shown that HIV-2 Vpx protein promotes the degradation of the SAMHD1, a host antiviral restriction factor [34–37].”
BackgroundDesign and potential of non-integrating lentiviral vectors
Shaw, A., & Cornetta, K. (2014) · Biomedicines · doi:10.3390/biomedicines2010014 · Cited by 60
Phosphorylation of murine SAMHD1 regulates its antiretroviral activity
Wittmann, S., Behrendt, R., Eissmann, K., Volkmann, B., Thomas, D., Ebert, T. S., Cribier, A., Benkirane, M., Hornung, V., Bouzas, N. F., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0229-6 · Cited by 67
Self-citationThe RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity
Rialdi, A., Hultquist, J. F., Jimenez‐Morales, D., Peralta, Z., Campisi, L., Fenouil, R., Moshkina, N., Wang, Z. Z., Laffleur, B., Kaake, R. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.021 · Cited by 69
Lee, E. J., Seo, J. H., Park, J., Vo, T. T. L., An, S., Bae, S., Le, H., Lee, H. S., Wee, H., Lee, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19704 · Cited by 60
“The siRNA sequence targeting human SAMHD1 corresponds to GAUUCAUUGUGGCCAUAUA as previously described [9].”
InfluentialThe structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1
Knecht, K. M., Buzovetsky, O., Schneider, C., Thomas, D., Srikanth, V., Kaderali, L., Tofoleanu, F., Reiss, K. M., Ferreirós, N., Geißlinger, G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805593115 · Cited by 59
“Journal of biomolecular screening 20(6):801-809.”
Roles of HIV-1 capsid in viral replication and immune evasion
Sage, V. L., Mouland, A. J., & Valiente‐Echeverría, F. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.010 · Cited by 63
Interactions between HIV-1 and the Cell-Autonomous Innate Immune System
Towers, G. J., & Noursadeghi, M. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.06.009 · Cited by 63
Early IFN type I response: Learning from microbial evasion strategies
Coccia, E. M., & Battistini, A. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.005 · Cited by 64
“This SAMHD1mediated restriction is overcome by the viral protein Vpx [124, 125] that is a HIV-2 and SIV accessory protein absent in HIV-1.”
BackgroundMelchjorsen, J. (2013) · Viruses · doi:10.3390/v5020470 · Cited by 64
“SAMHD1 has recently been identified as a HIV-1 restriction factor in cells of myeloid origin [260,261].”
BackgroundThe SAMHD1-mediated block of LINE-1 retroelements is regulated by phosphorylation
Herrmann, A., Wittmann, S., Thomas, D., Shepard, C., Kim, B., Ferreirós, N., & Gramberg, T. (2018) · Mobile DNA · doi:10.1186/s13100-018-0116-5 · Cited by 59
“The original article [1] contains an omission in the Methods.”
de Silva, S., Wang, F., Hake, T. S., Porcu, P., Wong, H. K., & Wu, L. J. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.311 · Cited by 58
“Non-dividing CD4+ T-cells, monocytes, macrophages and dendritic cells from healthy individuals express high levels of SAMHD1 protein and have significantly lower levels of intracellular dNTPs compared to activated CD4+ T-cells, while several leukemia/lymphoma CD4+ T-cell lines lack SAMHD1 protein expression and have i…”
BackgroundSchwefel, D., Boucherit, V., Christodoulou, E., Walker, P. A., Stoye, J. P., Bishop, K. N., & Taylor, I. A. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.004 · Cited by 60
“More recently, SAMHD1 was shown to be a factor that restricts HIV-1 replication in non-dividing myeloid-lineage cells and resting T cells (Baldauf et al., 2012; Berger et al., 2011; Descours et al., 2012; Hrecka et al., 2011; Laguette et al., 2011).”
Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection
Goujon, C., Schaller, T., Galão, R. P., Amie, S. M., Kim, B., Olivieri, K. C., Neil, S. J. D., & Malim, M. H. (2013) · Retrovirology · doi:10.1186/1742-4690-10-23 · Cited by 59
“As previously reported, reducing SAMHD1 protein levels increased the permissivity of PMA-treated (non-dividing) THP-1 cells by ~4-fold (Figure 3D) [7,15].”
BackgroundInfluentialSensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages
Decalf, J., Desdouits, M., Rodrigues, V., Gobert, F.-X., Gentili, M., Marques-Ladeira, S., Chamontin, C., Mougel, M., de Alencar, B. C., & Benaroch, P. (2017) · Journal of Virology · doi:10.1128/jvi.00147-17 · Cited by 60
“In human myeloid cells, such as monocyte-derived dendritic cells (MDDC) (12) or monocyte-derived macrophages (MDM) (13), HIV-1 infection initially appears poorly detected, if at all, and does not trigger detectable secretion of type I interferon (IFN).”
BackgroundInfluential
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.